Clinical Trial Update: Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer

View source ↗

Summary

A GlaxoSmithKline-sponsored clinical trial evaluating specific biomarkers in primary invasive breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Status: TERMINATED